Drugs with anticholinergic properties as a risk factor for cognitive impairment in elderly people: A population-based study

Journal of Clinical Psychopharmacology

Volumn 28, Issue 6, 2008, Pages 654-659

  Cancelli, Iacopo ^a   Gigli, Gian Luigi ^a,b   Piani, Antonella ^a   Zanchettin, Barbara ^a   Janes, Francesco ^a,b   Rinaldi, Adriana ^a   Valente, Mariarosaria ^a,b  

^a SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^b UNIVERSITY OF UDINE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; AMITRIPTYLINE; BIPERIDEN; CHLORDIAZEPOXIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CIMETIDINE; CLIDINIUM BROMIDE; CODEINE; DIAZEPAM; DIGOXIN; DIPYRIDAMOLE; FLURAZEPAM; FUROSEMIDE; HALOPERIDOL; ISOSORBIDE; NIFEDIPINE; OCTATROPINE METHYLBROMIDE; OLANZAPINE; ORPHENADRINE; OTILONIUM BROMIDE; OXYBUTYNIN; PAROXETINE; PERPHENAZINE; PHENOBARBITAL; PROMAZINE; PROPANTHELINE BROMIDE; RANITIDINE; THEOPHYLLINE; WARFARIN;

AGE DISTRIBUTION; AGED; AGING; ARTICLE; COGNITIVE DEFECT; DETERIORATION; DRUG ACTIVITY; DRUG USE; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; POPULATION RESEARCH; PRIORITY JOURNAL; RISK FACTOR; AGE; CHEMICALLY INDUCED DISORDER; COGNITION; CROSS-SECTIONAL STUDY; DRUG EFFECT; HEALTH SURVEY; ITALY; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; RISK; RISK ASSESSMENT;

AGE DISTRIBUTION; AGE FACTORS; AGED; AGED, 80 AND OVER; CHOLINERGIC ANTAGONISTS; COGNITION; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; ITALY; MALE; ODDS RATIO; POPULATION SURVEILLANCE; PSYCHIATRIC STATUS RATING SCALES; RISK ASSESSMENT; RISK FACTORS;

EID: 59049101149     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e31818ce849     Document Type: Article

References (27)

1. Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003;163:2716-2724.
2. Tollefson GD, Montague-Clouse J, Lancaster SP. The relationship of serum anticholinergic activity to mental status performance in an elderly nursing home population. J Neuropsychiatry Clin Neurosci. 1999;3: 314-319.
3. Tune L, Carr S, Hoag E, et al. Anticholinergic effects of drugs commonly prescribed for the elderly: potential means for assessing risk of delirium. Am J Psychiatry. 1992;149:1393-1394.
4. Landi F, Russo A, Liperoti R, et al. Anticholinergic drugs and physical function among frail elderly population. Clin Pharmacol Ther. 2007;81: 235-241.
5. Blazer DG, Federspiel CF, Ray WA, et al. The risk of anticholinergic toxicity in the elderly: a study of prescribing practices in two populations. J Gerontol. 1983;38:31-35.
6. Cao YJ, Mager DE, Simonsick, et al. Physical and cognitive performance and burden of anticholinergics, sedatives, and ACE inhibitors in older women. Clin Pharmacol Ther. 2008;83:422-429.
7. Lechevallier-Michel N, Molimard M, Dartigues JF, et al. Drugs with anticholinergic properties and cognitive performance in the elderly: results from the PAQUID Study. Br J Clin Pharmacol. 2005;59:143-151.
8. Ancelin ML, Artero S, Portet F, et al. Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study. BMJ. 2006;332:455-459.
9. Chew ML, Mulsant BH, Pollock BG. Serum anticholinergic activity and cognition in patients with moderate-to-severe dementia. Am J Geriatr Psychiatry. 2005;13:535-538.
10. Tune LE, Egeli S. Acetylcholine and delirium. Dement Geriatr Cogn Disord. 1999;10:342-344.
11. Han L, McCusker J, Cole M, et al. Use of medications with anticholinergic effect predicts clinical severity of delirium symptoms in older medical inpatients. Arch Intern Med. 2001;161:1099-1105.
12. Cancelli I, Marcon G, Balestrieri M. Factors associated with complex visual hallucinations during antidepressant treatment. Hum Psychopharmacol. 2004;19:577-584.
13. Cancelli I, Valentinis L, Merlino G, et al. Drugs with anticholinergic properties as a risk factor for psychosis in patients affected by Alzheimer's disease. Clin Pharmacol Ther. 2008;84:63-68.
14. Mintzer J, Burns A. Anticholinergic side-effects of drugs in elderly people. J R Soc Med. 2000;93:457-462.
15. Moore AR, O'Keeffe ST. Drug-induced cognitive impairment in the elderly. Drugs Aging. 1999;15:15-28.
16. Bottiggi KA, Salazar JC, Yu L, et al. Long-term cognitive impact of anticholinergic medications in older adults. Am J Geriatr Psychiatry. 2006;14:980-984.
17. WHO. International statistical classi?cation of diseases and related health problems. Available at: http://www.who.int/classi?cation/icd/en/. Accessed November 12, 2007.
18. WHO Collaborating Centre for Drug Statistics Methodology. Anatomical Therapeutics Chemical classi?cation system. Available at: http:// www.whocc.no/atcddd/. Accessed November 12, 2007.
19. Folstein MF, Folstein SE, McHug PH. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
20. Reisenberg B, Ferris SH, De Leon M, et al. The global deterioration scale for assessment of primary degenerative dementia. Am J Psychiatry. 1982;34:1136-1139.
21. Rudd KM, Raehl CL, Bond CA, et al. Methods for assessing drug- related anticholinergic activity. Pharmacotherapy. 2005;25:1592-1601.
22. Peters NL. Snipping the thread of life. Antimuscarinic side effects of medications in the elderly. Arch Intern Med. 1989;149:2414-2420.
23. Carnahan RM, Lund BC, Perry PJ, et al. The concurrent use of anticholinergics and cholinesterase inhibitors: rare event or common practice? J Am Geriatr Soc. 2004;52:2082-2087.
24. Mulsant BH, Pollock BG, Kirshner M, et al. Serum anticholinergic activity in a community-based sample of older adults: relationship with cognitive performance. Arch Gen Psychiatry. 2003;60:198-203.
25. Mulsant BH, Gangul M, Seaberg EC. The relationship between self- rated health and depressive symptoms in an epidemiological sample of community-dwelling older adults. J Am Geriatr Soc. 1997;45:954-958.
26. Bartus RT, Dean RL 3rd, Beer B, et al. The cholinergic hypothesis of geriatric memory dysfunction. Science. 1982;217:408-414.
27. Doraiswamy PM, Husain MM. Anticholinergic drugs and elderly people: a no brainer? Lancet Neurol. 2006;5:379-380